AbCellera Biologics Total Non Current Liabilities | ABCL

Annual Total Non Current Liabilities AbCellera Biologics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
326 M	228 M	217 M	189 M	172 M	71.5 M	5.34 M	3.45 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
326 M	3.45 M	152 M

Quarterly Total Non Current Liabilities AbCellera Biologics

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
358 M	322 M	323 M	328 M	246 M	228 M	235 M	231 M	228 M	217 M	219 M	223 M	200 M	189 M	196 M	160 M	171 M	172 M	170 M	114 M	83 M	71.5 M	71.5 M	71.5 M	71.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
358 M	71.5 M	196 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Фармсинтез LIFE	13.2 M	-	-	-	Russia
AbbVie ABBV	81.7 B	$ 257.12	0.86 %	$ 455 B	USA
Ayala Pharmaceuticals AYLA	497 K	-	-	$ 7.46 M	Israel
Amryt Pharma plc AMYT	302 M	-	-	$ 621 M	Britain
Evelo Biosciences EVLO	40.3 M	-	-14.46 %	$ 27.9 M	USA
ASLAN Pharmaceuticals Limited ASLN	24.8 M	-	-14.27 %	$ 1.7 M	Singapore
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Abeona Therapeutics ABEO	6.69 M	$ 5.42	0.18 %	$ 287 M	USA
iTeos Therapeutics ITOS	6.36 M	-	-	$ 411 M	USA
Galmed Pharmaceuticals Ltd. GLMD	44 K	$ 4.63	21.05 %	$ 20 M	Israel
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
BioXcel Therapeutics BTAI	1.4 M	$ 0.07	9.81 %	$ 855 K	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Cyclerion Therapeutics CYCN	70.5 M	$ 23.52	458.67 %	$ 98.9 M	USA
Lexicon Pharmaceuticals LXRX	235 M	$ 2.0	0.3 %	$ 726 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	25.6 M	$ 5.12	0.1 %	$ 981 M	Canada
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
NextCure NXTC	2.6 M	$ 7.0	0.55 %	$ 19.9 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
Nanobiotix S.A. NBTX	94.7 M	$ 37.01	0.27 %	$ 1.77 T	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 27.83	0.32 %	$ 4.69 B	USA
Axcella Health AXLA	26.4 M	-	-16.42 %	$ 249 M	USA
SQZ Biotechnologies Company SQZ	58.7 M	-	57.95 %	$ 12.8 M	USA
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Achieve Life Sciences ACHV	159 K	$ 7.06	0.41 %	$ 308 M	USA
Baudax Bio BXRX	65.4 M	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
Codiak BioSciences CDAK	119 M	-	-55.98 %	$ 2.15 M	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Avid Bioservices CDMO	21.2 M	-	-	$ 789 M	USA
AC Immune SA ACIU	14.7 M	$ 2.76	2.6 %	$ 278 M	Schweiz
Cerevel Therapeutics Holdings CERE	4.4 M	-	-	$ 7.29 B	USA
Aclaris Therapeutics ACRS	5.95 M	$ 5.32	1.27 %	$ 652 M	USA
Checkpoint Therapeutics CKPT	2.47 M	-	-	$ 169 M	USA
Adagene ADAG	158 M	$ 3.4	2.72 %	$ 201 M	China
ADC Therapeutics SA ADCT	341 M	$ 1.07	0.45 %	$ 136 M	Schweiz
ADMA Biologics ADMA	99.5 M	$ 9.23	0.16 %	$ 2.2 B	USA
Adaptive Biotechnologies Corporation ADPT	263 M	$ 24.2	0.08 %	$ 3.67 B	USA
Agenus AGEN	264 M	$ 6.94	0.73 %	$ 206 M	USA
Agios Pharmaceuticals AGIO	157 M	$ 33.6	0.16 %	$ 1.95 B	USA